| Adam Collier, | |
|
600 East Blvd, Elkhart, IN 46514-2483 | |
| (574) 524-8130 | |
| (574) 524-8138 |
| Full Name | Adam Collier |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 5 Years |
| Location | 600 East Blvd, Elkhart, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891333522 | NPI | - | NPPES |
| 300034071 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 28254463A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Elkhart General Hospital | Elkhart, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beacon Medical Group Inc | 1254243306 | 452 |
News Archive
Swedish and British scientists have shown using functional magnetic resonance imaging (fMRI) that the hormone oxytocin can inhibit feelings of anxiety in specific individuals. Their discovery might lead to a better understanding and the improved treatment of psychiatric affections in which people feel distressed when meeting others, such as in cases of autism and social phobia.
Cupid was obviously a full-term baby. It's fitting then that a researcher named Valentine and her colleagues will oversee a new multicenter National Institutes of Health study to determine whether an over the counter fatty acid supplement, called DHA (Docosahexaenoic acid, an omega-3 fatty acid), can assist with reducing early preterm births.
A new study shows that genetic pre-screening could reduce the number of screening tests needed to identify individuals at risk for osteoporotic fractures. Douglas P. Kiel, M.D., M.P.H., director of the Musculoskeletal Research Center in the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife, is an author on the report published this month in PLOS (Public Library of Science) Medicine.
Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.
› Verified 1 days ago
| Entity Name | Beacon Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
Swedish and British scientists have shown using functional magnetic resonance imaging (fMRI) that the hormone oxytocin can inhibit feelings of anxiety in specific individuals. Their discovery might lead to a better understanding and the improved treatment of psychiatric affections in which people feel distressed when meeting others, such as in cases of autism and social phobia.
Cupid was obviously a full-term baby. It's fitting then that a researcher named Valentine and her colleagues will oversee a new multicenter National Institutes of Health study to determine whether an over the counter fatty acid supplement, called DHA (Docosahexaenoic acid, an omega-3 fatty acid), can assist with reducing early preterm births.
A new study shows that genetic pre-screening could reduce the number of screening tests needed to identify individuals at risk for osteoporotic fractures. Douglas P. Kiel, M.D., M.P.H., director of the Musculoskeletal Research Center in the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife, is an author on the report published this month in PLOS (Public Library of Science) Medicine.
Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.
› Verified 1 days ago
| Entity Name | Northern Indiana Anesthesia Services, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083639660 PECOS PAC ID: 1456321413 Enrollment ID: O20040727001614 |
News Archive
Swedish and British scientists have shown using functional magnetic resonance imaging (fMRI) that the hormone oxytocin can inhibit feelings of anxiety in specific individuals. Their discovery might lead to a better understanding and the improved treatment of psychiatric affections in which people feel distressed when meeting others, such as in cases of autism and social phobia.
Cupid was obviously a full-term baby. It's fitting then that a researcher named Valentine and her colleagues will oversee a new multicenter National Institutes of Health study to determine whether an over the counter fatty acid supplement, called DHA (Docosahexaenoic acid, an omega-3 fatty acid), can assist with reducing early preterm births.
A new study shows that genetic pre-screening could reduce the number of screening tests needed to identify individuals at risk for osteoporotic fractures. Douglas P. Kiel, M.D., M.P.H., director of the Musculoskeletal Research Center in the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife, is an author on the report published this month in PLOS (Public Library of Science) Medicine.
Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.
› Verified 1 days ago
| Entity Name | Sda Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336605500 PECOS PAC ID: 3870825912 Enrollment ID: O20210819003335 |
News Archive
Swedish and British scientists have shown using functional magnetic resonance imaging (fMRI) that the hormone oxytocin can inhibit feelings of anxiety in specific individuals. Their discovery might lead to a better understanding and the improved treatment of psychiatric affections in which people feel distressed when meeting others, such as in cases of autism and social phobia.
Cupid was obviously a full-term baby. It's fitting then that a researcher named Valentine and her colleagues will oversee a new multicenter National Institutes of Health study to determine whether an over the counter fatty acid supplement, called DHA (Docosahexaenoic acid, an omega-3 fatty acid), can assist with reducing early preterm births.
A new study shows that genetic pre-screening could reduce the number of screening tests needed to identify individuals at risk for osteoporotic fractures. Douglas P. Kiel, M.D., M.P.H., director of the Musculoskeletal Research Center in the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife, is an author on the report published this month in PLOS (Public Library of Science) Medicine.
Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam Collier, 851 W 2800 N, Pleasant Grove, UT 84062-8027 Ph: (801) 641-2936 | Adam Collier, 600 East Blvd, Elkhart, IN 46514-2483 Ph: (574) 524-8130 |
News Archive
Swedish and British scientists have shown using functional magnetic resonance imaging (fMRI) that the hormone oxytocin can inhibit feelings of anxiety in specific individuals. Their discovery might lead to a better understanding and the improved treatment of psychiatric affections in which people feel distressed when meeting others, such as in cases of autism and social phobia.
Cupid was obviously a full-term baby. It's fitting then that a researcher named Valentine and her colleagues will oversee a new multicenter National Institutes of Health study to determine whether an over the counter fatty acid supplement, called DHA (Docosahexaenoic acid, an omega-3 fatty acid), can assist with reducing early preterm births.
A new study shows that genetic pre-screening could reduce the number of screening tests needed to identify individuals at risk for osteoporotic fractures. Douglas P. Kiel, M.D., M.P.H., director of the Musculoskeletal Research Center in the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife, is an author on the report published this month in PLOS (Public Library of Science) Medicine.
Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.
› Verified 1 days ago
Mr. Taqi Qays Abdu-as-salaam, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 500 N Nappanee St, Suite 11, Elkhart, IN 46514 Phone: 574-522-9922 | |
Mark Mcpherson, RN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 600 East Blvd, Elkhart, IN 46514 Phone: 574-523-3193 | |
Ms. Barbara Ann Doherty, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1004 Parkway Ave, Suite B, Elkhart, IN 46516 Phone: 574-522-9922 Fax: 574-522-9926 | |
Naznin Lalani, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 500 N Nappanee, Ste 11b, Elkhart, IN 46514 Phone: 574-522-9922 | |
Joshua Stewart, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 600 East Blvd, Elkhart, IN 46514 Phone: 574-294-2621 | |
Lindsay Vasil, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1513 E Jackson Blvd, Elkhart, IN 46516 Phone: 574-523-3193 | |
Denise Christine Brown, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 600 East Blvd, Elkhart, IN 46514 Phone: 574-523-3193 Fax: 574-523-3463 |